Salivary microbiota and metabolic phenotype of patients with recurrent aphthous ulcers

被引:2
|
作者
Dong, Yunmei [1 ]
Lou, Fangzhi [1 ]
Yan, Li [1 ]
Luo, Shihong [1 ]
Zhang, Yingying [1 ]
Liu, Yang [1 ]
Lv, Shiping [1 ]
Xu, Jingyi [1 ]
Kang, Ning [1 ]
Luo, Zhuoyan [1 ]
Liu, Yiyun [2 ]
Pu, Juncai [2 ]
Ji, Ping [1 ]
Jin, Xin [1 ,3 ]
机构
[1] Chongqing Med Univ, Coll Stomatol, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, NHC Key Lab Diag & Treatment Brain Funct Dis, Chongqing, Peoples R China
[3] Chongqing Med Univ, Stomatol Hosp, 426 Songshi North Rd, Chongqing, Peoples R China
关键词
16S rRNA sequencing; liquid chromatography-mass spectrometry; recurrent aphthous ulcers; salivary metabolites; salivary microbiota; STOMATITIS; STREPTOCOCCUS; ANTIGENS; DISEASE;
D O I
10.1111/odi.14852
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectivesRecurrent aphthous ulcer (RAU) is a prevalent oral mucosal disease, affecting around 20% of the global population. It can greatly impair the quality of life for affected individuals. However, the exact etiology of RAU remains unknown.Subjects and Methods16S rRNA sequencing (16S rRNA-seq) and non-targeted liquid chromatography-mass spectrometry (LC-MS) were employed to investigate the salivary microbiota and metabolic phenotype between RAU patients (N = 61) and healthy controls (HCs) (N = 105).ResultsFindings from 16S rRNA -seq indicated reduced oral microbial diversity in RAU patients compared to HCs, but increased interactions. Clinical variables did not show any significant association with the overall diversity of oral microbiota in RAU patients. However, significant correlations were observed between specific microorganisms and clinical variables. LC-MS results revealed dysregulation of amino acid, lipid, nucleotide, and caffeine metabolism in RAU patients. Furthermore, correlation analysis of 16S rRNA-seq and LC-MS data revealed a significant association between salivary microbiota and metabolites in RAU patients.ConclusionsOur study revealed notable differences in salivary microbiota and metabolic profiles between RAU patients and HCs, indicating a strong link between oral microbiota dysbiosis, metabolic disturbances, and the onset and progression of RAU.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] RECURRENT APHTHOUS ULCERS AND NICOTINE
    BITTOUN, R
    MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (07) : 471 - 472
  • [22] Salivary calprotectin levels in patients with recurrent aphthous stomatitis
    Atalay, B.
    Koray, M.
    Akgul, S.
    Oguz, F. Savran
    Mumcu, G.
    ORAL DISEASES, 2014, 20 : 9 - 9
  • [23] Serum and Salivary Parameters in Patients with Recurrent Aphthous Ulcerations
    Picek, Pavle
    Andabak Rogulj, Ana
    Boras, Vanja Vucicevic
    Brailo, Vlaho
    Cigic, Livija
    Canjuga, Ivana
    Ladika-Davidovic, Blazenka
    ACTA STOMATOLOGICA CROATICA, 2012, 46 (01) : 43 - 49
  • [24] Oral microbiota in patients with major recurrent aphthous stomatitis
    Carlsson, M.
    Sjoberg, F.
    Ostman, S.
    Jontell, M.
    ORAL DISEASES, 2012, 18 : 12 - 12
  • [25] Serum lipid levels in patients with minor recurrent aphthous ulcers
    Gulcan, Erim
    AMERICAN JOURNAL OF DENTISTRY, 2015, 28 (03): : 133 - 136
  • [26] Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers
    Avci, E.
    Akarslan, Z. Z.
    Erten, H.
    Coskun-Cevher, S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (05) : 355 - 360
  • [27] EFFECT OF TETRACYCLINES ON COLLAGENASE ACTIVITY IN PATIENTS WITH RECURRENT APHTHOUS ULCERS
    HAYRINENIMMONEN, R
    SORSA, T
    PETTILA, J
    KONTTINEN, YT
    TERONEN, O
    MALMSTROM, M
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (06) : 269 - 272
  • [28] SOCIOECONOMIC STATUS AND RECURRENT APHTHOUS ULCERS
    SHIP, II
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1966, 73 (01): : 120 - &
  • [29] ETIOLOGY OF RECURRENT APHTHOUS ULCERS (RAU)
    MAURICE, M
    MIKHAIL, W
    AZIZ, M
    BARSOUM, M
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1987, 101 (09): : 917 - 920
  • [30] Amlexanox for the treatment of recurrent aphthous ulcers
    Bell, J
    CLINICAL DRUG INVESTIGATION, 2005, 25 (09) : 555 - 566